Increased risk of invasive bacterial infections in African people with sickle-cell disease: A systematic review and meta-analysis

The Lancet Infectious Diseases

Volumn 10, Issue 5, 2010, Pages 329-337

  Ramakrishnan, Meenakshi ^a   Moïsi, Jennifer C ^b   Klugman, Keith P ^c,d   Iglesias, Jesus M Feris ^e   Grant, Lindsay R ^b   Mpoudi Etame, Mireille ^f   Levine, Orin S ^b  

^a Independent Consultant   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e Hospital Infantil Dr Robert Reid Cabral   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; DISEASE ASSOCIATION; HAEMOPHILUS INFLUENZAE TYPE B; HIGH RISK POPULATION; HUMAN; LABORATORY TEST; MENINGITIS; MORTALITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; ANIMAL; BACTERIAL MENINGITIS; INFANT; META ANALYSIS; PRESCHOOL CHILD; RISK FACTOR;

AFRICA; ANEMIA, SICKLE CELL; ANIMALS; BACTEREMIA; BACTERIAL INFECTIONS; CHILD, PRESCHOOL; HUMANS; INFANT; MENINGITIS, BACTERIAL; PNEUMONIA; RISK FACTORS;

EID: 77951923437     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70055-4     Document Type: Review

References (50)

1. Modell B, Darlison M Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008, 86:480-487.
2. Weatherall DJ, Clegg JB Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001, 79:704-712.
3. Serjeant GR Mortality from sickle cell disease in Africa. BMJ 2005, 330:432-433.
4. Weatherall DJ, Hofman K, Rodgers G, Ruffin J, Hrynkow S A case for developing north-south partnerships for research in sickle cell disease. Blood 2005, 105:921-923.
5. Ibidapo MO, Akinyanju OO Acute sickle cell syndromes in Nigerian adults. Clin Lab Haematol 2000, 22:151-155.
6. Koko J, Kani F, Reymond-Yeni A, Onewin-Andjanga G, Moussavou A, Gahouma D Bacterial infections in children with sickle cell disease in Libreville. Arch Pediatr 1999, 6:1131-1132. (in French).
7. Omanga U Incidence of bacterial infections in Zairese children with sickle cell anemia (author's transl). Ann Pediatr (Paris) 1981, 28:525-527. (in French).
8. Modell B, Darlison M Modell's haemoglobinopathologist's almanac 2007, UCL Centre for Health Informatics and Multiprofessional Education, London, (accessed March 17, 2010). http://www.chime.ucl.ac.uk/work-areas/cab/hb/world.afr.pdf.
9. Management of haemoglobin disorders: report of a joint WHO-TIF meeting, Nicosia, Cyprus, 16-18 November 2007 2008, WHO, World Health Organization, Geneva, (accessed March 18, 2010). http://www.who.int/genomics/WHO-TIF_genetics_final.pdf.
10. Makani J, Williams TN, Marsh K Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol 2007, 101:3-14.
11. Davies SC, Brozovic M The presentation, management and prophylaxis of sickle cell disease. Blood Rev 1989, 3:29-44.
12. Serjeant GR, Ndugwa CM Sickle cell disease in Uganda: a time for action. East Afr Med J 2003, 80:384-387.
13. Athale UH, Chintu C Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia. East Afr Med J 1994, 71:388-391.
14. Adewuyi JO Morbidity of sickle cell disease in early childhood. J Trop Pediatr 1988, 34:93.
15. Sickle cell anemia: report by the Secretariat 2006, WHO, World Health Organization, Geneva, (accessed March 18, 2010). http://apps.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf.
16. Wong WY, Overturf GD, Powars DR Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination. Clin Infect Dis 1992, 14:1124-1136.
17. Van Beneden C, Whitney CG, Levine OS Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49(RR-9):1-35.
18. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease-life expectancy and risk factors for early death. N Engl J Med 1994, 330(123):1639-1644.
19. Tshilolo L, Kafando E, Sawadogo M, et al. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health 2008, 122:933-941.
20. Kizito ME, Mworozi E, Ndugwa C, Serjeant GR Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?. Arch Dis Child 2007, 92:21-23.
21. Akinyanju O, Johnson AO Acute illness in Nigerian children with sickle cell anaemia. Ann Trop Paediatr 1987, 7:181-186.
22. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 1986, 109:579-585.
23. Hematology: basic principles and practice 2005, Churchill Livingstone, Oxford. 4th edn. R. Hoffman (Ed.).
24. Johnson HL, Knoll MD, Levine OS, et al. Serotype distribution of invasive pneumococcal disease among children globally: results from the Pneumococcal Global Serotype Project 2008 (accessed April 1, 2010). http://www.vaccineamc.org/files/TPP_Codebook.pdf.
25. Knoll MD, O'Brien KL, Henkle E, et al. Global literature review of Haemophilus influenzae type b and Streptococcus pneumoniae invasive disease among children less than five years of age 1980-2005 2009, World Health Organization, Geneva, (accessed March 18, 2010). http://whqlibdoc.who.int/hq/2009/who_ivb_09.02_eng.pdf.
26. Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med 2009, 7:47.
27. Akinyanju OO Bacterial infection in sickle cell disease in Lagos, Nigeria 1981, University of London, London.
28. Okuonghae HO, Nwankwo MU, Offor EC Pattern of bacteraemia in febrile children with sickle cell anaemia. Ann Trop Paediatr 1993, 13:55-64.
29. Akuse RM Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission. J Trop Pediatr 1996, 42:318-323.
30. Esimai VC, Aladekomo TA, Oseni SB, Adeoba EA, Ariyibi SS Incidence of bacteraemia among children with severe anaemia in Wesley Guild Hospital, Ilesa, Nigeria. J Trop Pediatr 1995, 41:50-51.
31. Lontie M, Vandepitte J, Gatti F, Makulu A Bilan etiologique et epidemiologique de 474 cas de meningite microbienne observes a Kinshasa (Republique du Zaire). Ann Soc Belge Med Trop 1973, 53:619-632.
32. Omanga U, Muganga N, Kapepela M Bacterial septicemias in children with homozygous sickle cell anemia: analysis of 69 cases. Ann Pediatr (Paris) 1989, 36:315-318. (in French).
33. Chiron JP, Laurens A, Denis F Bacterial meningitis and sickle-cell disease. Med Afr Noire 1980, 27:37-42.
34. Eeckels R, Gatti F, Renoirte AM Abnormal distribution of haemoglobin genotypes in Negro children with severe bacterial infections. Nature 1967, 216:382.
35. Nottidge VA Pneumococcal meningitis in sickle cell disease in childhood. Am J Dis Child 1983, 137:29-31.
36. Williams TN, Uyoga S, Macharia A, et al. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet 2009, 374:1364-1370.
37. Diallo D, Tchernia G Sickle cell disease in Africa. Curr Opin Hematol 2002, 9:111-116.
38. Juwah AI, Nlemadim A, Kaine W Clinical presentation of severe anemia in pediatric patients with sickle cell anemia seen in Enugu, Nigeria. Am J Hematol 2003, 72:185-191.
39. Vernacchio L, Neufeld EJ, MacDonald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 1998, 133:275-278.
40. Vernacchio L, Romero-Steiner S, Martinez JE, et al. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease. J Infect Dis 2000, 181:1162-1166.
41. Reinert P, Benkerrou M, de Montalembert M, et al. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease. Pediatr Infect Dis J 2007, 26:1105-1109.
42. Davies EG, Riddington C, Lottenberg R, Dower N Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev 2004, 1. CD003885.
43. French N, Nachman S, Pelton SI Immunogenicity in high-risk and immunocompromised children and adults. Pneumococcal vaccines 2008, 261-275. ASM Press, Washington, DC. G.R. Siber, K.P. Klugman, P.H. Makela (Eds.).
44. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008, 121:562-569.
45. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007, 44:1428-1433.
46. Hausdorff WP, Bryant J, Paradiso PR, Siber GR Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000, 30:100-121.
47. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000, 30:122-140.
48. Cutts FT, Zaman SMA, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365:1139-1146.
49. Brent AJ, Ahmed I, Ndiritu MN, et al. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 2006, 367:482-488.
50. Update: world's poorest children among first to receive new life-saving pneumococcal vaccines GAVI Alliance, (accessed March 26, 2010). http://www.vaccineamc.org/updatemar23_10.html.